Improving pregnancy high-blood-pressure care in community clinics
Official title: Optimizing implementation strategies for guideline-concordant hypertensive disorders of pregnancy care in community clinics
Funded at Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center · NIH-11354306 · Data updated 2026-11-12
A plan to help doctors in community clinics follow guidelines to prevent preeclampsia with low-dose aspirin for pregnant people at risk.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center NIH-funded |
| Lab location | 1 site (Torrance, United States) |
| Project start | August 20, 2026 |
| Project end | June 30, 2029 |
| Funding year | 2026 |
| Award (this year) | $161,500 |
| NIH project number | 1R34HL186380-01 |
| Project ID | NIH-11354306 on NIH RePORTER |
Who could benefit from this research
✓Could help
Pregnant people at high risk for hypertensive disorders who receive care in community, resource-constrained clinics.
✕Less likely to help
Pregnant people not at risk for HDP or those not receiving care in the involved clinics may not directly benefit.
What this research studies
This project aims to figure out the best ways to implement existing guidelines for using low-dose aspirin during pregnancy in resource-limited clinic settings. It builds on prior findings that aspirin prescribing is inconsistent and tests how different support tools and education can work together to improve care. The focus is on feasibility and acceptability of the proposed implementation components before a larger trial. The work uses a planning grant to prepare for a multisite study that could ultimately help reduce severe HDP outcomes for pregnant people.
Why it matters
Potential benefit: If successful, this work could lead to more consistent aspirin use in high-risk pregnancies and lower the risk of preeclampsia and related complications.
How similar studies have gone: Previous work showed mixed success; this project tests optimized, combined strategies in real-world clinics.
Where this research is happening
-
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Torrance, United States Active
Researchers
- Principal investigator: Blebu, Bridgette Emefa — Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Study coordinator: Blebu, Bridgette Emefa
Related research
Other NIH-funded projects on the same topics.
-
How air pollution during pregnancy affects fetal growth over time
This study looks at how air pollution affects the growth of babies in the womb during pregnancy, using ultrasound images to track changes over time, and it aims to help expectant parents understand when their babies might be most at risk from pollution.
-
Postoperative Pain Guidelines for Pregnancy: Safer, Patient-Centered Opioid Use
We’re creating patient-friendly guidelines to help doctors manage pain after delivery and surgery in pregnant people, aiming to reduce opioid overuse and improve safety.
-
HPV and pregnancy risk: a big study following 1,280 pregnancies
A large pregnancy study at UTMB looks at whether human papillomavirus (HPV) during pregnancy is linked to problems like preterm birth.
-
Understanding how where you live and personal factors during pregnancy affect a child’s risk for obesity and metabolic problems
This project looks at how neighborhood conditions and individual factors during pregnancy may influence a child’s risk of obesity and metabolic health as they grow.
-
Blocking cancer-causing cMYC tricks after pregnancy changes in the breast
Researchers are testing how pregnancy and aging reshape the breast before cancer risk, using patient-reinformed models to see if it changes how dangerous cMYC signals behave.
-
SSRI use during pregnancy: effects on placental blood flow and inflammation
This grant studies how antidepressants (SSRIs) used during pregnancy might affect the placenta and inflammation, and whether a 5-HT2 receptor blocker could mitigate any negative effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.